Ovarian Cancer's Silent Threat: High Mortality and Diagnostic Challenges for American Women
Ovarian cancer remains the deadliest gynecological cancer in the United States, with the American Cancer Society estimating over 21,000 new diagnoses and approximately 12,450 deaths this year. The disease is often diagnosed at an advanced stage, with nearly 80% of cases identified at Stage 3 or 4, significantly reducing survival rates. Symptoms such as abdominal pain, bloating, and irregular bleeding are often subtle and misattributed to other conditions, delaying diagnosis. The five-year relative survival rate for late-stage ovarian cancer is about 30%, compared to over 90% for breast cancer and more than 98% for prostate cancer. This high mortality rate is compounded by the fact that ovarian cancer symptoms are often dismissed or overlooked, leading to late detection. 
